Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

irwpresse_en's profile

Blog
Endeavour Silver Announces Board and Management Updates
Endeavour Silver Announces Board and Management Updates

George Paspalas Appointed to Board of Directors, Don Gray Retiring as COO, Luis Castro Appointed as COO, Gord Bussieres Appointed as Vice President, Projects

 

VANCOUVER, British Columbia,

Edison Lithium Acquires Option for Joutel North-West and Gagne Gold Properties from Globex
Edison Lithium Acquires Option for Joutel North-West and Gagne Gold Properties from Globex

Vancouver, British Columbia, March 2, 2026 Edison Lithium Corp. (TSXV: EDDY, OTC PINK: EDDYF; FWB: VV0) (“Edison” or the “Company”) is pleased to announce that it has entered into a

Silver One Commences Core Drilling for Geotechnical Pit Slope Study at Its Candelaria, Project Nevada
Silver One Commences Core Drilling for Geotechnical Pit Slope Study at Its Candelaria, Project Nevada

Vancouver, British Columbia--(March 2, 2026) - Silver One Resources Inc. (TSXV: SVE) (OTCQX: SLVRF) (FSE: BRK1) (“Silver One” or the “Company”) is pleased to announce that has commenced a

Toogood Gold Signs Binding LOI to Acquire the Table Mountain Project, a District-Scale, Undrilled Low-Sulphidation Epithermal Gold-Silver System in Nevada
Toogood Gold Signs Binding LOI to Acquire the Table Mountain Project, a District-Scale, Undrilled Low-Sulphidation Epithermal Gold-Silver System in Nevada

Vancouver, BC, March 2, 2026 – Toogood Gold Corp. (TSXV: TGC; OTCQB: TGGCF; FSE: D3P) (“Toogood” or the “Company”) today announced that it has entered into a binding Letter of Intent dated

Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress
Anixa Biosciences to Host 2026 Annual Meeting of Stockholders and Provide Corporate Update Highlighting Recent Clinical and Regulatory Progress

Presentation to Review Ovarian Cancer CAR-T Survival Observations and Dose Escalation, as well as Final Phase 1 Breast Cancer Vaccine Data

 

SAN JOSE, Calif., March 2, 2026 – Anixa